SIC
IRMD icon

SJS Investment Consulting’s iRadimed IRMD Stock Holding History

SJS Investment Consulting’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192 Hold
2
– – ﹤0.01% 2483
2026
Q1 		$193 Hold
2
– – ﹤0.01% 1990
2025
Q4 		$195 Buy
+2
New +$172 ﹤0.01% 1815

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SJS Investment Consulting's IRMD Position: Q2 2026 in Review

SJS Investment Consulting held its iRadimed (IRMD) position steady in Q2 2026 at 2 shares worth $192. The position accounts for ﹤0.01% of the portfolio, ranked #2483.

SJS Investment Consulting first reported a position in IRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $195 in Q4 2025. 214 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • SJS Investment Consulting held 2 shares of iRadimed worth $192 as of Q2 2026.
  • SJS Investment Consulting left its iRadimed share count unchanged in Q2 2026.
  • iRadimed made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2483 holding.
  • SJS Investment Consulting first reported a position in iRadimed in Q4 2025 and has held it in 3 quarters since.
  • SJS Investment Consulting's iRadimed position peaked at $195 in Q4 2025.
  • 214 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.